JP2005538045A5 - - Google Patents

Download PDF

Info

Publication number
JP2005538045A5
JP2005538045A5 JP2003584115A JP2003584115A JP2005538045A5 JP 2005538045 A5 JP2005538045 A5 JP 2005538045A5 JP 2003584115 A JP2003584115 A JP 2003584115A JP 2003584115 A JP2003584115 A JP 2003584115A JP 2005538045 A5 JP2005538045 A5 JP 2005538045A5
Authority
JP
Japan
Prior art keywords
fibrinogen
lmw
hmw
vivo
variant
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2003584115A
Other languages
English (en)
Japanese (ja)
Other versions
JP2005538045A (ja
JP5083928B2 (ja
Filing date
Publication date
Priority claimed from NL1020426A external-priority patent/NL1020426C2/nl
Application filed filed Critical
Publication of JP2005538045A publication Critical patent/JP2005538045A/ja
Publication of JP2005538045A5 publication Critical patent/JP2005538045A5/ja
Application granted granted Critical
Publication of JP5083928B2 publication Critical patent/JP5083928B2/ja
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

JP2003584115A 2002-04-18 2003-04-07 細胞の成長及び内方成長に関してフィブリンマトリックスの特性の修飾 Expired - Lifetime JP5083928B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
NL1020426 2002-04-18
NL1020426A NL1020426C2 (nl) 2002-04-18 2002-04-18 Modificatie van de eigenschappen van een fibrinematrix met betrekking tot groei en ingroei van cellen.
PCT/NL2003/000293 WO2003087160A1 (en) 2002-04-18 2003-04-07 Modification of the properties of a fibrin matrix with respect to growth and ingrowth of cells

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2010088946A Division JP5395726B2 (ja) 2002-04-18 2010-04-07 細胞の成長及び内方成長に関してフィブリンマトリックスの特性の修飾

Publications (3)

Publication Number Publication Date
JP2005538045A JP2005538045A (ja) 2005-12-15
JP2005538045A5 true JP2005538045A5 (enExample) 2006-06-01
JP5083928B2 JP5083928B2 (ja) 2012-11-28

Family

ID=29244993

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2003584115A Expired - Lifetime JP5083928B2 (ja) 2002-04-18 2003-04-07 細胞の成長及び内方成長に関してフィブリンマトリックスの特性の修飾
JP2010088946A Expired - Lifetime JP5395726B2 (ja) 2002-04-18 2010-04-07 細胞の成長及び内方成長に関してフィブリンマトリックスの特性の修飾
JP2010106630A Expired - Lifetime JP5248547B2 (ja) 2002-04-18 2010-05-06 細胞の成長及び内方成長に関してフィブリンマトリックスの特性の修飾

Family Applications After (2)

Application Number Title Priority Date Filing Date
JP2010088946A Expired - Lifetime JP5395726B2 (ja) 2002-04-18 2010-04-07 細胞の成長及び内方成長に関してフィブリンマトリックスの特性の修飾
JP2010106630A Expired - Lifetime JP5248547B2 (ja) 2002-04-18 2010-05-06 細胞の成長及び内方成長に関してフィブリンマトリックスの特性の修飾

Country Status (10)

Country Link
US (2) US7867519B2 (enExample)
EP (1) EP1495051B1 (enExample)
JP (3) JP5083928B2 (enExample)
AT (1) ATE403679T1 (enExample)
AU (1) AU2003230455A1 (enExample)
CA (1) CA2482893C (enExample)
DE (1) DE60322687D1 (enExample)
DK (1) DK1495051T3 (enExample)
NL (1) NL1020426C2 (enExample)
WO (1) WO2003087160A1 (enExample)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004067704A2 (en) 2003-01-30 2004-08-12 Prochon Biotech Ltd. Freeze-dried fibrin matrices and methods for preparation thereof
US7067123B2 (en) 2003-04-29 2006-06-27 Musculoskeletal Transplant Foundation Glue for cartilage repair
US7901457B2 (en) 2003-05-16 2011-03-08 Musculoskeletal Transplant Foundation Cartilage allograft plug
US7335508B2 (en) 2004-07-22 2008-02-26 Prochon Biotech Ltd. Porous plasma protein matrices and methods for preparation thereof
US7837740B2 (en) 2007-01-24 2010-11-23 Musculoskeletal Transplant Foundation Two piece cancellous construct for cartilage repair
US7815926B2 (en) 2005-07-11 2010-10-19 Musculoskeletal Transplant Foundation Implant for articular cartilage repair
WO2007035778A2 (en) 2005-09-19 2007-03-29 Histogenics Corporation Cell-support matrix and a method for preparation thereof
WO2008081463A2 (en) 2007-01-04 2008-07-10 Hepacore Ltd. Water soluble reactive derivatives of carboxy polysaccharides and fibrinogen conjugates thereof
US8435551B2 (en) 2007-03-06 2013-05-07 Musculoskeletal Transplant Foundation Cancellous construct with support ring for repair of osteochondral defects
EP2265220A1 (en) 2008-03-05 2010-12-29 Musculoskeletal Transplant Foundation Cancellous constructs, cartilage particles and combinations of cancellous constructs and cartilage particles
JP5819725B2 (ja) 2008-07-09 2015-11-24 プロフィブリックス ビーブイ 組換えフィブリノゲン
CA2785594C (en) * 2010-01-08 2018-04-17 Profibrix Bv Fibrinogen preparations enriched in fibrinogen with an extended alpha chain
KR20120125465A (ko) * 2010-01-08 2012-11-15 프로피브릭스 비.브이. 건조 분말 피브린 실란트
WO2012140650A2 (en) 2011-04-12 2012-10-18 Hepacore Ltd. Conjugates of carboxy polysaccharides with fibroblast growth factors and variants thereof
US8999376B2 (en) 2012-02-03 2015-04-07 Xcede Technologies, Inc. Tissue patch
KR101567053B1 (ko) 2013-09-30 2015-11-09 한국원자력의학원 방사선 피폭에 의한 간 손상 예측용 바이오마커 및 그 예측방법
US10077420B2 (en) 2014-12-02 2018-09-18 Histogenics Corporation Cell and tissue culture container
US10588998B2 (en) 2015-08-07 2020-03-17 Xcede Technologies, Inc. Adhesive compositions and related methods
US9540548B1 (en) 2015-08-07 2017-01-10 Xcede Technologies, Inc. Adhesive compositions and related methods
US9833538B2 (en) 2015-08-07 2017-12-05 Xcede Technologies, Inc. Adhesive compositions and related methods

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1142581A3 (en) * 1990-11-27 2002-09-11 American National Red Cross Tissue sealant and growth factor containing compositions that promote accelerated wound healing
EP0759762A4 (en) * 1994-05-02 1999-09-01 Squibb & Sons Inc RECOMBINANT FIBRIN CHAINS, FIBRIN AND FIBRIN APPROVED
DE69629010T2 (de) * 1995-01-16 2004-04-15 Baxter International Inc., Deerfield Selbsttragende flächengebilde aus vernetztem fibrin zur hemmung von postoperativen adhäsionen
US6037457A (en) * 1997-01-31 2000-03-14 The University Of North Carolina At Chapel Hill Method for recombinant fibrinogen production
AU8336098A (en) * 1997-06-05 1998-12-21 Omrix Biopharmaceuticals S.A. Fibrinogen concentrate from human plasma
US6946140B1 (en) * 1999-02-09 2005-09-20 The Research Foundation Of State University Of New York Methods and compositions for enhancing fibroblast migration
AU4351000A (en) * 1999-04-15 2000-11-02 Research Foundation Of State University Of New York, The Cellular matrix system and use thereof
AU771557B2 (en) * 1999-06-01 2004-03-25 Vivolution A/S Prevention of post surgical adhesions using a fibrin monomer sealant

Similar Documents

Publication Publication Date Title
JP2005538045A5 (enExample)
DE602004010493D1 (de) Kaugummi in der form von mehrschichttabletten
DE60313597D1 (de) Topische pharmazeutische zusammensetzungen mit proanthocyanidinen, glycyrrhetinic säure und telmesteine zur behandlung von dermatitis
NO20020770L (no) Anvendelse av monoaminoksidaseinhibitorer for fremstilling av legemidler egnet for behandling av obesitas
DE60239648D1 (de) Pharmazeutische Zusammensetzungen zur Behandlung von Asthma
PL372809A1 (en) Substituted 1,3-diphenylprop-2-en-1-one derivatives and preparation and uses thereof
ATE486840T1 (de) Modifizierte formen pharmazeutisch aktiver agenzien und verwendungen dafür
JP2003503454A5 (enExample)
ATE446313T1 (de) Muteine von tränen-lipocalin
AU2003239609A1 (en) 2-Furancarboxylic acid hydrazides and pharmaceutical compositions containing the same
DE50206657D1 (de) Pharmazeutische zusammensetzung zur behandlung von multiple sklerose
DE60318839D1 (de) 2,6-chinolinyl- und 2,6-naphthylderivate und deren verwendungen zur behandlung von vla-4 bezogenen krankheiten
JP2005237328A5 (enExample)
ATE272628T1 (de) Substituierte gamma-phenyl-delta-lactone und deren analoge, und ihre verwendungen
ATE323092T1 (de) Pyridopyrimidinon-derivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen
RU2001132140A (ru) Рекомбинантный рецептор коллагена на тромбоцитах гликопротеин VI и его применение в фармацевтике
ATE323693T1 (de) Calciumkanalantagonisten vom n-typ zur behandlung von schmerzen
JP2005509503A5 (enExample)
PT1401405E (pt) Composicoes farmaceuticas orais com biodisponibilidade melhorada
DE60204232D1 (de) Antagonisten für calciumkanäle vom n-typ zur behandlung von schmerzen
JP2005525089A5 (enExample)
IS8430A (is) Lyf sem inniheldur (2R)-2-própýloktansýru sem virka efnisþáttinn
ATE286894T1 (de) 2h-1-benzopyran-derivate, prozesse zu ihrer herstellung und pharmazeutische zusammensetzungen
JP2004517961A5 (enExample)
DE602005027231D1 (de) Cylglycerolen und therapeutischen verwendungen derselben